Digital Commons Network^™

Hospital-Based Use Of Thromboprophylaxis In Patients With Covid-19, A. C. Spyropoulos, W. Ageno, E. S. Barnathan

Journal Articles

No abstract provided.

Covid-19 And Older Adults: What We Know, Z Shahid, R Kalayanamitra, B Mcclafferty, D Kepko, D Ramgobin, R Patel, Cs Aggarwal, R Vunnam, N Sahu, R Jain, +3 Additional Authors

Journal Articles

No abstract provided.

Emergence Of Institutional Antithrombotic Protocols For Coronavirus 2019., Kp Cohoon, G Mahé, Aj Tafur, Ac Spyropoulos

Journal Articles

No abstract provided.

Incidence Of Arrhythmias And Electrocardiographic Abnormalities In Symptomatic Pediatric Patients With Pcr-Positive Sars-Cov-2 Infection, Including Drug-Induced Changes In The Corrected Qt Interval, S Samuel, Ra Friedman, C Sharma, M Ganigara, E Mitchell, C Schleien, Ad Blaufox

Journal Articles

No abstract provided.

Varying Presentations And Favourable Outcomes Of Covid-19 Infection In Children And Young Adults With Sickle Cell Disease: An Additional Case Series With Comparisons To Published Cases., A Appiah-Kubi, S Acharya, C Fein Levy, A Vlachos, G Ostovar, K Murphy, A Farrell, D Brower, Jm Lipton, B Aygun, +1 Additional Authors

Journal Articles

No abstract provided.

Safety Of Psychotropic Medications In People With Covid-19: Evidence Review And Practical Recommendations, G Ostuzzi, D Papola, C Gastaldon, G Schoretsanitis, F Bertolini, F Amaddeo, A Cuomo, R Emsley, C U. Correll, C Barbui, +12 Additional Authors

Journal Articles

No abstract provided.

A 3d-Printed Nasopharyngeal Swab For Covid-19 Diagnostic Testing., J. Ford, T. Goldstein, S. Trahan, A. Neuwirth, K. Tatoris, S. Decker

Journal Articles

The nasopharyngeal swab is a critical component of the COVID-19 testing kit. Supply chain remains greatly impacted by the pandemic. Teams from USF Health Radiology and Northwell Health System developed a 3D-printed stopgap alternative. This descriptive study details the workflow and provides guidance for hospital-based 3D printing labs to leverage the design to make a positive impact on the pandemic. Swab use is also outlined, and the early information regarding clinical use is described, including an ongoing multicenter trial methodology.

A Meta-Analysis On The Effects Of Hydroxychloroquine On Covid-19., N. Hussain, E. Chung, J. J. Heyl, B. Hussain, M. C. Oh, C. Pinon, S. Boral, D. Chun, B. Babu

Journal Articles

Introduction Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread throughout the world with a large medical and economic impact. On March 12, 2020, the World Health Organization (WHO) classified SARS-CoV-2 as a pandemic. As a result of this worldwide public health crisis, politicians, elected officials, and healthcare professionals emergently began trialing hydroxychloroquine (HCQ) in efforts to treat and prevent the transmission of the virus. This meta-analysis was performed to assess the effects of HCQ on patients with COVID-19. Methods This meta-analysis adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRIMA) guidelines. Selected …

A Pediatric Infectious Disease Perspective Of Sars-Cov-2 And Covid-19 In Children., A. L. Shane, A. I. Sato, C. Kao, F. C. Adler-Shohet, S. B. Vora, J. Ery, J. Auletta, S. Nachman, M. K. Kainth, K. Kotloff, +15 Additional Authors

Journal Articles

Understanding the role that children play in the clinical burden and propagation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for novel coronavirus (COVID-19) infections is emerging. While the severe manifestations and acute clinical burden of COVID-19 has largely spared children compared to adults, understanding the epidemiology, clinical presentation, diagnostics, management, and prevention opportunities as well as the social and behavioral impacts on child health is vital. Foremost is clarifying the contribution of asymptomatic and mild infections to transmission within the household and community and the clinical and epidemiologic significance of uncommon severe post-infectious complications. Herein we summarize the …

Electroconvulsive Therapy Practice Changes In Older Individuals Due To Covid-19: Expert Consensus Statement, M. I. Lapid, S. Seiner, H. Heintz, A. P. Hermida, L. Nykamp, S. N. Sanghani, M. Mueller, G. Petrides, B. P. Forester

Journal Articles

© 2020 American Association for Geriatric Psychiatry The ubiquitous coronavirus 2019 (COVID-19) pandemic has required healthcare providers across all disciplines to rapidly adapt to public health guidelines to reduce risk while maintaining quality of care. Electroconvulsive therapy (ECT), which involves an aerosol-generating procedure from manual ventilation with a bag mask valve while under anesthesia, has undergone drastic practice changes in order to minimize disruption of treatment in the midst of COVID-19. In this paper, we provide a consensus statement on the clinical practice changes in ECT specific to older adults based on expert group discussions of ECT practitioners across the …

Covid-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered By Novel Coronavirus Infection And The Inflammatory Response?, S. J. Ferrando, L. Klepacz, S. Lynch, M. Tavakkoli, R. Dornbush, R. Baharani, Y. Smolin, A. Bartell

Journal Articles

No abstract provided.

Incidental Pet/Ct Findings Of Suspected Covid-19 In A Region Of High Prevalence., A. M. Franceschi, M. Clifton, O. Ahmed, R. Matthews, D. Franceschi

Journal Articles

We describe a case of suspected COVID-19 pneumonia in a 61-year-old male with known primary central nervous system diffuse large B-cell lymphoma (DLBCL) who underwent restaging PET/CT during the initial peak of infection of COVID-19 pneumonia within the New York region. At the time of his routine PET-CT to assess for disease progression, typical CT imaging features of COVID-19 pneumonia were identified. Upon further investigation, the patient was asymptomatic, and his infection status remained unknown. He was subsequently lost to follow-up with his COVID-19 status pending.

Management Of Neonates After Postpartum Discharge And All Children In The Ambulatory Setting During The Coronavirus Disease 2019 (Covid-19) Pandemic, K. L. Harriel, D. Nolt, S. Moore, S. Kressly, H. H. Bernstein

Journal Articles

PURPOSE OF REVIEW: The present coronavirus disease 2019 (COVID-19) pandemic has created additional challenges with an increased number of presumed healthy, full-term newborns being discharged at 24 h after delivery. Short lengths of stay raise the possibility of mother-infant dyads being less ready for discharge, defined as at least one of the three informants (i.e., mother, pediatrician, and obstetrician) believing that either the mother and/or infant should stay longer than the proposed time of discharge. This public health crisis has reduced the number of in-person well child visits, negatively impacting vaccine receipt, and anticipatory guidance. RECENT FINDINGS: Extra precautions should …

Pregnancy And Neonatal Outcomes In Sars-Cov-2 Infection: A Systematic Review., R. S. Chamseddine, F. Wahbeh, F. Chervenak, L. J. Salomon, B. Ahmed, A. Rafii

Journal Articles

With the emergence of SARS-CoV-2 and its rapid spread, concerns regarding its effects on pregnancy outcomes have been growing. We reviewed 245 pregnancies complicated by maternal SARS-CoV-2 infection across 48 studies listed on PubMed and MedRxiv. The most common clinical presentations were fever (55.9%), cough (36.3%), fatigue (11.4%), and dyspnea (12.7%). Only 4.1% of patients developed respiratory distress. Of all patients, 89.0% delivered via cesarean section (n = 201), with a 33.3% rate of gestational complications, a 35.3% rate of preterm delivery, and a concerning 2.5% rate of stillbirth delivery or neonatal death. Among those tested, 6.45% of newborns were …

The Global Impact Of Covid-19 On Gastrointestinal Endoscopy Units: An International Survey Of Endoscopists, M. Alboraie, A. Piscoya, Q. T. Tran, R. B. Mendelsohn, A. S. Butt, L. Lenz, P. Alavinejad, M. H. Emara, S. Iqbal, S. Vignesh, +10 Additional Authors

Journal Articles

© 2020 Pan-Arab Association of Gastroenterology Background & study aims: Corona virus disease-19 (COVID-19) pandemic has markedly impacted routine medical services including gastrointestinal (GI) endoscopy. We aim to report the real-life performance in high volume GI endoscopy units during the pandemic. Patients and methods: A web-based survey covering all aspects of daily performance in GI endoscopy units was sent to endoscopy units worldwide. Responses were collected and data were analyzed to reveal the effect of COVID-19 pandemic on endoscopy practice. Results: Participants from 48 countries (n = 163) responded to the survey with response rate of 67.35%. The majority (85%) …

A Parallel-Group, Multicenter Randomized, Double-Blinded, Placebo-Controlled, Phase 2/3, Clinical Trial To Test The Efficacy Of Pyridostigmine Bromide At Low Doses To Reduce Mortality Or Invasive Mechanical Ventilation In Adults With Severe Sars-Cov-2 Infection: The Pyridostigmine In Severe Covid-19 (Pisco) Trial Protocol, S. Fragoso-Saavedra, D. A. Iruegas-Nunez, A. Quintero-Villegas, H. B. García-González, I. Nuñez, S. L. Carbajal-Morelos, B. M. Audelo-Cruz, S. Arias-Martínez, Y. Caro-Vega, S. I. Valdés-Ferrer, +7 Additional Authors

Journal Articles

© 2020, The Author(s). Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the causative agent of coronavirus disease 2019 (COVID-19), may lead to severe systemic inflammatory response, pulmonary damage, and even acute respiratory distress syndrome (ARDS). This in turn may result in respiratory failure and in death. Experimentally, acetylcholine (ACh) modulates the acute inflammatory response, a neuro-immune mechanism known as the inflammatory reflex. Recent clinical evidence suggest that electrical and chemical stimulation of the inflammatory reflex may reduce the burden of inflammation in chronic inflammatory diseases. Pyridostigmine (PDG), an ACh-esterase inhibitor (i-ACh-e), increases the half-life of endogenous ACh, therefore …

Clinical, Radiological, And Molecular Findings Of Acute Encephalitis In A Covid-19 Patient: A Rare Case Report., S. B. Sattar, M. A. Haider, Z. Zia, M. Niazi, Q. Z. Iqbal

Journal Articles

We report a case of encephalitis in a young male patient with severe coronavirus disease 2019 (COVID-19) who initially presented with typical symptoms of fever, dry cough, and shortness of breath but later on developed acute respiratory distress syndrome and required mechanical ventilation. Two days post-extubation, the patient developed new-onset generalized tonic-clonic seizures and confusion. MRI of the brain was done and it showed an abnormal signal in the bilateral medial cortical frontal region. His cerebral spinal fluid (CSF) analysis revealed a characteristic picture of a viral infection with a high white blood cell count and normal glucose and protein …

Cytokine Elevation In Severe And Critical Covid-19: A Rapid Systematic Review, Meta-Analysis, And Comparison With Other Inflammatory Syndromes., D. E. Leisman, L. Ronner, R. Pinotti, M. D. Taylor, P. Sinha, C. S. Calfee, A. V. Hirayama, F. Mastroiani, C. J. Turtle, C. S. Deutschman, +2 Additional Authors

Journal Articles

The description of a so-called cytokine storm in patients with COVID-19 has prompted consideration of anti-cytokine therapies, particularly interleukin-6 antagonists. However, direct systematic comparisons of COVID-19 with other critical illnesses associated with elevated cytokine concentrations have not been reported. In this Rapid Review, we report the results of a systematic review and meta-analysis of COVID-19 studies published or posted as preprints between Nov 1, 2019, and April 14, 2020, in which interleukin-6 concentrations in patients with severe or critical disease were recorded. 25 COVID-19 studies (n=1245 patients) were ultimately included. Comparator groups included four trials each in sepsis (n=5320), cytokine …

Hrs/Ehra/Aphrs/Lahrs/Acc/Aha Worldwide Practice Update For Telehealth And Arrhythmia Monitoring During And After A Pandemic, N. Varma, N. F. Marrouche, L. Aguinaga, C. M. Albert, E. Arbelo, J. I. Choi, M. K. Chung, G. Conte, L. M. Epstein, P. D. Varosy, +13 Additional Authors

Journal Articles

No abstract provided.

Coagulation Disorders In Coronavirus Infected Patients: Covid-19, Sars-Cov-1, Mers-Cov And Lessons From The Past, D. Giannis, I. A. Ziogas, P. Gianni

Journal Articles

© 2020 Elsevier B.V. Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in China and rapidly spread worldwide. This novel strain is highly transmittable and severe disease has been reported in up to 16% of hospitalized cases. More than 600,000 cases have been confirmed and the number of deaths is constantly increasing. COVID-19 hospitalized patients, especially those suffering from severe respiratory or systemic manifestations, fall under the spectrum of the acutely ill medical population, which is at increased venous thromboembolism risk. Thrombotic complications seem to emerge as an …

Time To Develop Therapeutic Antibodies Against Harmless Proteins Colluding With Sepsis Mediators?, J. Li, G. Bao, H. Wang

Journal Articles

Sepsis refers to a systemic inflammatory response syndrome resulting from microbial infections, and is partly attributable to dysregulated inflammation and associated immunosuppression. A ubiquitous nuclear protein, HMGB1, is secreted by activated leukocytes to orchestrate inflammatory responses during early stages of sepsis. When it is released by injured somatic cells at overwhelmingly higher quantities, HMGB1 may induce macrophage pyroptosis and immunosuppression, thereby impairing the host's ability to eradicate microbial infections. A number of endogenous proteins have been shown to bind HMGB1 to modulate its extracellular functions. Here, we discuss an emerging possibility to develop therapeutic antibodies against harmless proteins that collude …

A Double-Blind, Placebo-Controlled, Phase Ii, Randomized Study Of Lovastatin Therapy In The Treatment Of Mildly Active Rheumatoid Arthritis, C. Aranow, J. Cush, M. B. Bolster, C. C. Striebich, M. Dall'era, M. Mackay, E. Olech, T. Frech, B. Diamond, A. Davidson Mbbs, +14 Additional Authors

Journal Articles

© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors (statins) are standard treatment for hyperlipidaemia. In addition to lipid-lowering abilities, statins exhibit multiple anti-inflammatory effects. The objectives of this study were to determine whether treatment of patients with RA with lovastatin decreased CRP or reduced disease activity. Methods: We conducted a randomized double-blind placebo-controlled 12 week trial of lovastatin vs placebo in 64 RA patients with mild clinical disease activity but an elevated CRP. The primary efficacy end point was the reduction …

Role Of Nutraceuticals In Covid-19 Mediated Liver Dysfunction., M. Sikander, S. Malik, A. Rodriguez, M. M. Yallapu, A. S. Narula, S. K. Satapathy, V. Dhevan, S. C. Chauhan, M. Jaggi

Journal Articles

COVID-19 is known as one of the deadliest pandemics of the century. The rapid spread of this deadly virus at incredible speed has stunned the planet and poses a challenge to global scientific and medical communities. Patients with COVID-19 are at an increased risk of co-morbidities associated with liver dysfunction and injury. Moreover, hepatotoxicity induced by antiviral therapy is gaining importance and is an area of great concern. Currently, alternatives therapies are being sought to mitigate hepatic damage, and there has been growing interest in the research on bioactive phytochemical agents (nutraceuticals) due to their versatility in health benefits reported …

Hmgb1 As A Potential Biomarker And Therapeutic Target For Severe Covid-19, R. Chen, Y. Huang, J. Quan, J. Liu, H. Wang, T. R. Billiar, M. T. Lotze, H. J. Zeh, R. Kang, D. Tang

Journal Articles

© 2020 The Author(s) HMGB1; COVID-19; Cell culture; Cell death; Inflammation; Infectious disease; Immunology; Microbiology; Virology

Dedicated Area Within The Emergency Department Versus An Outside Dedicated Area For Evaluation And Management Of Suspected Coronavirus Disease 2019., G. Garra, S. Gupta, S. Ferrante, W. Apterbach

Journal Articles

Background

The circumstances of the coronavirus disease 2019 pandemic necessitated an alternate operations strategy for efficient patient management. Alternate care sites were a viable option for managing emergency department (ED) surge in previous epidemics and disasters.

Objective

This study describes the development of an alternate care site and evaluates efficiency by comparing key performance indicators between an ad hoc nested respiratory evaluation unit (NRU) within the ED and an alternate care site outside the ED.

Methods

This was a cohort study of 2 care models in the same ED during 2 different time periods. As coronavirus disease 2019 surged in …

Liver Injury In Covid-19: The Hepatic Aspect Of The Respiratory Syndrome — What We Know So Far, P. Anirvan, P. Bharali, M. Gogoi, P. J. Thuluvath, S. P. Singh, S. K. Satapathy

Journal Articles

© 2020. All Rights Reserved. The 2019 novel coronavirus disease (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious threat to global public health. Although primarily, the infection causes lung injury, liver enzyme abnormalities have also been reported to occur during the course of the disease. We conducted an extensive literature review using the PubMed database on articles covering a broad range of issues related to COVID-19 and hepatic injury. The present review summarizes available information on the spectrum of liver involvement, the possible mechanisms and risk factors of liver injury due to SARS-CoV-2 …

Clinical Characteristics And Outcomes Of Critically Ill Patients With Covid-19 Admitted To An Intensive Care Unit In London: A Prospective Observational Cohort Study, R. J. Thomson, J. Hunter, J. Dutton, J. Schneider, M. Khosravi, A. Casement, K. Dhadwal, D. Martin

Journal Articles

© 2020 Thomson et al. Background Cohorts of severely ill patients with COVID-19 have been described in several countries around the globe, but to date there have been few published reports from the United Kingdom (UK). Understanding the characteristics of the affected population admitted to intensive care units (ICUs) in the UK is crucial to inform clinical decision making, research and planning for future waves of infection. Methods We conducted a prospective observational cohort study of all patients with COVID-19 admitted to a large UK ICU from March to May 2020 with follow-up to June 2020. Data were collected from …

Identification Of A Brainstem Locus That Inhibits Tumor Necrosis Factor., A. M. Kressel, T. Tsaava, Y. A. Levine, E. H. Chang, M. E. Addorisio, Q. Chang, B. J. Burbach, V. A. Pavlov, S. S. Chavan, K. J. Tracey, +4 Additional Authors

Journal Articles

In the brain, compact clusters of neuron cell bodies, termed nuclei, are essential for maintaining parameters of host physiology within a narrow range optimal for health. Neurons residing in the brainstem dorsal motor nucleus (DMN) project in the vagus nerve to communicate with the lungs, liver, gastrointestinal tract, and other organs. Vagus nerve-mediated reflexes also control immune system responses to infection and injury by inhibiting the production of tumor necrosis factor (TNF) and other cytokines in the spleen, although the function of DMN neurons in regulating TNF release is not known. Here, optogenetics and functional mapping reveal cholinergic neurons in …

The Value Proposition For Pathologists: A Population Health Approach, B. S. Ducatman, A. M. Ducatman, J. M. Crawford, M. Laposata, F. Sanfilippo

Journal Articles

© The Author(s) 2020. The transition to a value-based payment system offers pathologists the opportunity to play an increased role in population health by improving outcomes and safety as well as reducing costs. Although laboratory testing itself accounts for a small portion of health-care spending, laboratory data have significant downstream effects in patient management as well as diagnosis. Pathologists currently are heavily engaged in precision medicine, use of laboratory and pathology test results (including autopsy data) to reduce diagnostic errors, and play leading roles in diagnostic management teams. Additionally, pathologists can use aggregate laboratory data to monitor the health of …

Molecular Pathology Economics 101: An Overview Of Molecular Diagnostics Coding, Coverage, And Reimbursement A Report Of The Association For Molecular Pathology, A. N. Sireci, J. L. Patel, L. Joseph, M. C. Hiemenz, O. C. Rosca, S. K. Caughron, S. A. Thibault-Sennett, T. L. Burke, D. L. Aisner

Journal Articles

No abstract provided.